Literature DB >> 18476072

Tubo-ovarian abscess formation in users of intrauterine devices remote from insertion: a report of three cases.

M R Toglia1, J I Schaffer.   

Abstract

BACKGROUND: The association between tubo-ovarian abscess formation and the presence of an intrauterine device (IUD) is well recognized. It has been suggested that the risk of upper-genital-tract infection is highest during the immediate period following the insertion of an IUD, returning to baseline by 5 months postinsertion. We present 3 cases of women who, 10-21 years after insertion of their IUDs, developed tubo-ovarian abscesses that were not causally related to sexually transmitted diseases (STDs) or actinomycetes. CASES: Three women, ages 39-47 years, presented to our gynecology service for evaluation of abdominal pain. One woman had bilateral tubo-ovarian abscesses and the other 2 had unilateral tubo-ovarian abscesses. All 3 were IUD users, with an interval from IUD insertion to presentation of 10-21 years. In each case, the cervical cultures for gonorrhea and chlamydia were negative at presentation and the sexual history was not consistent with an STD mode of spread. All 3 women initially received broad-spectrum antibiotics, but 2 eventually required definitive surgical therapy.
CONCLUSION: Long-term users of IUDs remain at risk for serious, indolent pelvic infections. These women should be counseled by their gynecologists on an ongoing basis as to this persistent risk. Tubo-ovarian abscess should be strongly considered in the differential diagnosis of an IUD user who presents with an adnexal mass, fever, or abdominal pain.

Entities:  

Year:  1996        PMID: 18476072      PMCID: PMC2364476          DOI: 10.1155/S106474499600018X

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  9 in total

1.  Unilateral tubo-ovarian abscess and intrauterine contraceptive devices.

Authors:  M Y Dawood; S J Birnbaum
Journal:  Obstet Gynecol       Date:  1975-10       Impact factor: 7.661

2.  The intrauterine device and tubo-ovarian abscess.

Authors:  E S Taylor; J H McMillan; B E Greer; W Droegemueller; H E Thompson
Journal:  Am J Obstet Gynecol       Date:  1975-10-15       Impact factor: 8.661

Review 3.  Pelvic inflammatory disease with intrauterine device use: a reassessment.

Authors:  E Kessel
Journal:  Fertil Steril       Date:  1989-01       Impact factor: 7.329

4.  Abdominal wall Actinomyces abscess associated with an intrauterine device. A case report.

Authors:  M Pearlman; A C Frantz; W S Floyd; S Faro
Journal:  J Reprod Med       Date:  1991-05       Impact factor: 0.142

5.  Tuboovarian abscess and the intrauterine device (Majzlin Spring).

Authors:  S Duckman; J Suarez; P Tantakesem
Journal:  Am J Obstet Gynecol       Date:  1973-04-15       Impact factor: 8.661

6.  Tubo-ovarian actinomycosis and the IUCD.

Authors:  D W Purdie; M J Carty; T I McLeod
Journal:  Br Med J       Date:  1977-11-26

Review 7.  Intrauterine devices and pelvic inflammatory disease: recent developments.

Authors:  D A Grimes
Journal:  Contraception       Date:  1987-07       Impact factor: 3.375

8.  Bacteriological colonisation of uterine cavity: role of tailed intrauterine contraceptive device.

Authors:  R A Sparks; B G Purrier; P J Watt; M Elstein
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-11

9.  The intrauterine device and pelvic inflammatory disease revisited: new results from the Women's Health Study.

Authors:  N C Lee; G L Rubin; R Borucki
Journal:  Obstet Gynecol       Date:  1988-07       Impact factor: 7.661

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.